Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25161 | EP6 | 1353567-32-4 | 98% Min. |  |
| EP6 is a 5-lipoxygenase (5-LO) inhibitor. 5-LO is a crucial enzyme of the arachidonic | ||||
| 25160 | Elzovantinib | 2271119-26-5 | 98% Min. |  |
| Elzovantinib, also known as TPX-0022 and CSF1R-IN-2, is an orally bioavailable CSF1R | ||||
| 25159 | APS6-45 | 2188236-41-9 | 98% Min. |  |
| APS6-45 is a tumor calibrated inhibitor, showing unique polypharmacology. APS6-45 sho | ||||
| 25158 | DS68591889 | 2488609-21-6 | ≧98.0% |  |
| DS68591889 (PTDSS1i) specifically inhibits PTDSS1, which catalyzes serine incorporati | ||||
| 25156 | ARN14494 | 1037837-27-6 | ≧98.0% |  |
| ARN14494 is a Selective Serine Palmitoyltransferase (SPT) Inhibitor which is a key en | ||||
| 25157 | ALT-007 | 2035010-37-6 | ≧98.0% |  |
| ALT-007 is an orally bioavailable SPT inhibitor that is more potent than myriocin, sa | ||||
| 25151 | Nivegacetor ( Synonyms: RG-6289, RO-7269162) | 2443487-67-8 | ≧98.0% |  |
| Nivegacetor (RG-6289, RO-7269162) is an oral gamma-secretase modulator. | ||||
| 25150 | Ranosidenib | 2301974-60-5 | ≧98.0% |  |
| Ranosidenib, also known as HMPL-306, is an isocitrate dehydrogenase (IDH) inhibitor. | ||||
| 25149 | Safusidenib | 1898206-17-1 | ≧98.0% |  |
| Safusidenib, also known as DS-1001, is an oral isocitrate dehydrogenase [NADP] cytopl | ||||
| 25148 | Atebimetinib | 2669009-92-9 | ≧98.0% |  |
| Atebimetinib (IMM-1-104) is an oral, small-molecule allosteric inhibitor of the MEK1 | ||||
| 25147 | MAT2A-IN-9 ( GSK4362676 ) | 2439277-80-0 | ≧98.0% |  |
| MAT2A-IN-9 ( GSK4362676 ), is a 2-oxoquinazoline derivative, is a potent MAT2A (methi | ||||
| 25146 | Chiauranib | 1256349-48-0 | 98% Min. |  |
| Chiauranib also known as orally available, small molecule inhibitor of select serine- | ||||